Europe vaccine rollout 'unacceptably slow', says WHO

The organisation said the slow rollout was "prolonging the pandemic" and described Europe's virus situation as "more worrying than we have seen in several months."

AFP
April 01, 2021 / 04:33 PM IST

The World Health Organization on Thursday slammed Europe's vaccine rollout as "unacceptably slow" which it said was prolonging the pandemic as the region sees a "worrying" surge in coronavirus infections.

"Vaccines present our best way out of this pandemic... However, the rollout of these vaccines is unacceptably slow," WHO director for Europe Hans Kluge said in a statement.

"We must speed up the process by ramping up manufacturing, reducing barriers to administering vaccines, and using every single vial we have in stock, now," he said.

To date, only 10 percent of the region's total population have received one vaccine dose, and four percent have completed a full vaccine series, the organisation said.

The WHO's European region comprises 53 countries and territories and includes Russia and several Central Asian nations.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The organisation said the slow rollout was "prolonging the pandemic" and described Europe's virus situation as "more worrying than we have seen in several months."

Five weeks ago, the weekly number of new cases in Europe had dipped to under one million, but "last week saw increasing transmission of Covid-19 in the majority of countries in the WHO European region, with 1.6 million new cases," it said.

The total number of deaths in Europe "is fast approaching one million and the total number of cases about to surpass 45 million," it said, noting that Europe was the second-most affected region after the Americas.

Worrying new variants

The UN body warned that the rapid spread of the virus could increase the risk of the emergence of worrying new variants.

"The likelihood of new variants of concern occurring increases with the rate at which the virus is replicating and spreading, so curbing transmission through basic disease control actions is crucial," Dorit Nitzan, WHO Europe's regional emergency director, said in the statement.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

New infections were increasing in every age group except in people aged 80 years and older, as vaccinations of that age group begin to show effect.

The WHO said the British variant of the virus was now the predominant one in Europe, and was present in 50 countries.

"As this variant is more transmissible and can increase the risk of hospitalisation, it has a greater public health impact and additional actions are required to control it," it said.

Those actions included expanded testing, isolation, contact tracing, quarantine and genetic sequencing.

Meanwhile, the WHO said lockdowns "should be avoided by timely and targeted public health interventions", but should be used when the disease "overstretches the ability of health services to care for patients adequately."

It said 27 countries in its European region were in partial or full nationwide lockdown, with 21 imposing nighttime curfews.

Follow our full coverage of the coronavirus pandemic here.
AFP
TAGS: #coronavirus #COVID-19 vaccine #Europe #Health #WHO #World News
first published: Apr 1, 2021 04:33 pm